| Company | Total Drugs In Pipeline | Next Company Event |
| A.P. Pharma, Inc. |
1
|
None specified.
|
| Aastrom Biosciences, Inc. |
0
|
None specified.
|
| Acadia Pharmaceuticals Inc |
0
|
None specified.
|
| Accelrys, Inc. |
0
|
None specified.
|
| Access Pharmaceuticals, Inc. |
0
|
None specified.
|
| Accuray Incorporated |
0
|
None specified.
|
| Achillion Pharmaceuticals, Inc. |
0
|
None specified.
|
| Acorda Therapeutics |
1
|
None specified.
|
| ACRUX LTD |
1
|
FDA Decision on 11/22/2010
|
| Acura Pharmaceuticals, Inc. |
1
|
None specified.
|
| Acusphere, Inc. |
0
|
None specified.
|
| Adamis Pharmaceuticals Corp |
0
|
None specified.
|
| Adeona Pharmaceuticals, Inc. |
0
|
None specified.
|
| Adolor Corporation |
1
|
None specified.
|
| Advanced Life Sciences Holdings, Inc. |
0
|
None specified.
|
| Adventrx Pharmaceuticals, Inc. |
0
|
None specified.
|
| AEterna Zentaris Inc. |
1
|
None specified.
|
| Affymax, Inc. |
1
|
None specified.
|
| Affymetrix, Inc. |
0
|
None specified.
|
| Albany Molecular Research, Inc. |
0
|
None specified.
|
| Alexion Pharmaceuticals, Inc. |
0
|
None specified.
|
| Alexza Pharmaceuticals, Inc. |
6
|
FDA Decision on 10/11/2010
|
| Alkermes, Inc. |
1
|
FDA Decision on 10/12/2010
|
| Allergan, Inc. |
0
|
None specified.
|
| Alliance Pharmaceutical Corp. |
0
|
None specified.
|
| Allos Therapeutic |
0
|
None specified.
|
| Alseres Pharmaceuticals, Inc. |
0
|
None specified.
|
| Amgen Inc. |
0
|
None specified.
|
| Amicas, Inc. |
0
|
None specified.
|
| Amylin Pharmaceuticals, Inc. |
2
|
FDA Decision on 10/22/2010
|
| Anadys Pharmaceuticals, Inc. |
0
|
None specified.
|
| Analysts International Corporation |
0
|
None specified.
|
| Anavex Life Sciences Corp |
1
|
None specified.
|
| Angiotech Pharmac |
0
|
None specified.
|
| Anika Therapeutic |
0
|
None specified.
|
| Antigenics Inc. |
0
|
None specified.
|
| Applied NeuroSolutions Inc. |
0
|
None specified.
|
| Aradigm Corporation |
0
|
None specified.
|
| ARCA biopharma, Inc. |
0
|
None specified.
|
| Ardea Biosciences |
0
|
None specified.
|
| Arena Pharmaceuticals Inc. |
1
|
FDA Panel Review on 09/15/2010
|
| Argonaut Technologies, Inc |
0
|
None specified.
|
| Ariad Pharmaceuti |
0
|
None specified.
|
| ArQule, Inc. |
0
|
None specified.
|
| Array BioPharma Inc. |
0
|
None specified.
|
| Arrowhead Research Corporation |
0
|
None specified.
|
| AstraZeneca plc |
1
|
None specified.
|
| Athersys, Inc. |
0
|
None specified.
|
| AutoImmune Inc. |
0
|
None specified.
|
| Auxilium Pharmaceuticals, Inc. |
0
|
None specified.
|
| AVANIR Pharmaceuticals |
1
|
FDA Decision on 10/30/2010
|
| AVAX Technologies, Inc. |
0
|
None specified.
|
| AVI BioPharma, In |
0
|
None specified.
|
| BioCryst Pharmaceuticals, Inc. |
0
|
None specified.
|
| Biodel Inc |
1
|
FDA Decision on 10/30/2010
|
| Bioelectronics Corp |
1
|
None specified.
|
| Biogen Idec Inc |
0
|
None specified.
|
| Biolase Technology, Inc. |
0
|
None specified.
|
| BioMarin Pharmace |
0
|
None specified.
|
| Biomimix, Inc. |
0
|
None specified.
|
| Biomoda, Inc. |
0
|
None specified.
|
| Bionovo Inc. |
6
|
None specified.
|
| Bio-Reference Lab |
0
|
None specified.
|
| BioSante Pharmaceuticals, Inc. |
0
|
None specified.
|
| Biostar Pharmaceuticals, Inc. |
0
|
None specified.
|
| Biovail Corporation |
0
|
None specified.
|
| Biovest International, Inc. |
0
|
None specified.
|
| Bristol Myers Squibb Co. |
1
|
None specified.
|
| Caliper Life Scie |
0
|
None specified.
|
| Cambridge Heart, Inc. |
0
|
None specified.
|
| Cardica, Inc |
0
|
None specified.
|
| Cardima, Inc. |
0
|
None specified.
|
| Cardiome Pharma Corp |
0
|
None specified.
|
| Cardiovascular Systems, Inc. |
0
|
None specified.
|
| Cardium Therapeutics Inc |
0
|
None specified.
|
| CAS Medical Systems, Inc. |
0
|
None specified.
|
| Catalyst Pharmaceutical Partners, Inc. |
0
|
None specified.
|
| Celera Corporatio |
0
|
None specified.
|
| Celgene Corporati |
0
|
None specified.
|
| Cell Genesys, Inc |
0
|
None specified.
|
| Cell Therapeutics, Inc. |
1
|
None specified.
|
| Cel-Sci Corporation |
2
|
None specified.
|
| Cephalon, Inc. |
1
|
None specified.
|
| Cepheid |
0
|
None specified.
|
| Cerus Corporation |
0
|
None specified.
|
| Charles River Lab |
0
|
None specified.
|
| Chelsea Therapeutics International Ltd. |
0
|
None specified.
|
| ChemGenex Pharmaceuticals Limited |
1
|
None specified.
|
| CombinatoRx, Incorporated |
1
|
None specified.
|
| Commonwealth Biot |
0
|
None specified.
|
| Compugen Ltd. |
0
|
None specified.
|
| Corcept Therapeutics Incorporated |
0
|
None specified.
|
| Cornerstone Thera |
0
|
None specified.
|
| Cortex Pharmaceuticals |
0
|
None specified.
|
| CPEX Pharmaceuticals, Inc. |
0
|
None specified.
|
| Crucell NV |
0
|
None specified.
|
| CryoLife, Inc. |
0
|
None specified.
|
| Curis, Inc. |
0
|
None specified.
|
| Cyclacel Pharmaceuticals, Inc. |
0
|
None specified.
|
| Cynosure, Inc. |
0
|
None specified.
|
| Cypress Bioscience, Inc. |
1
|
None specified.
|
| Cytomedix, Inc. |
0
|
None specified.
|
| Cytori Therapeutics Inc. |
0
|
None specified.
|
| CytRx Corporation |
0
|
None specified.
|
| DARA BioSciences, Inc. |
0
|
None specified.
|
| Delcath Systems, Inc. |
0
|
None specified.
|
| Dendreon Corporation |
1
|
None specified.
|
| DENTSPLY International Inc. |
0
|
None specified.
|
| Depomed |
0
|
None specified.
|
| DOV Pharmaceutical, Inc. |
0
|
None specified.
|
| DUSA Pharmaceutic |
0
|
None specified.
|
| Dyax Corp. |
0
|
None specified.
|
| Dynavax Technologies Corporation |
0
|
None specified.
|
| Echo Therapeutics, Inc. |
0
|
None specified.
|
| Elan Corporation |
0
|
None specified.
|
| Emisphere Technologies, Inc. |
0
|
None specified.
|
| Endologix, Inc. |
0
|
None specified.
|
| EnteroMedics Inc. |
0
|
None specified.
|
| EntreMed, Inc. |
0
|
None specified.
|
| Enzo Biochem, Inc. |
0
|
None specified.
|
| Enzon Pharmaceuticals, Inc. |
0
|
None specified.
|
| eResearch Technol |
0
|
None specified.
|
| Ergo Science Corporation |
0
|
None specified.
|
| Exact Sciences Co |
0
|
None specified.
|
| Exelixis, Inc. |
0
|
None specified.
|
| Facet Biotech Corporation |
0
|
None specified.
|
| Forbes Medi-Tech |
0
|
None specified.
|
| Forest Laboratories, Inc. |
0
|
None specified.
|
| Generex Biotechnology Corporation |
0
|
None specified.
|
| Genta Incorporated |
1
|
None specified.
|
| Gentium S.p.A. |
0
|
None specified.
|
| GenVec, Inc. |
1
|
None specified.
|
| Genzyme Corporation |
1
|
None specified.
|
| Geron Corporation |
0
|
None specified.
|
| Gilead Sciences |
0
|
None specified.
|
| GlaxoSmithKline |
0
|
Earnings on 10/21/2010
|
| GTC Biotherapeutics, Inc. |
0
|
None specified.
|
| GTx, Inc. |
0
|
None specified.
|
| H&Q Healthcare Investors |
0
|
None specified.
|
| Hana BioSciences |
1
|
None specified.
|
| Hansen Medical, Inc. |
0
|
None specified.
|
| Health Discovery Corporation |
0
|
None specified.
|
| Helicos BioSciences Corp |
0
|
None specified.
|
| Hemagen Diagnostics, Inc. |
0
|
None specified.
|
| Hemispherx BioPharma, Inc |
0
|
None specified.
|
| Heska Corporation |
0
|
None specified.
|
| Hollis-Eden Pharmaceuticals Inc. |
0
|
None specified.
|
| Hospira, Inc. |
0
|
None specified.
|
| Human Genome Sciences |
1
|
FDA Decision on 10/04/2010
|
| iCAD, INC. |
0
|
None specified.
|
| Icagen, Inc. |
0
|
None specified.
|
| Idenix Pharmaceut |
0
|
None specified.
|
| IDEXX Laboratorie |
0
|
None specified.
|
| Illumina, Inc. |
0
|
None specified.
|
| Imaging 3, Inc |
0
|
None specified.
|
| ImmuCell Corporation |
0
|
None specified.
|
| Immunomedics, Inc. |
1
|
None specified.
|
| Incyte Corporatio |
0
|
None specified.
|
| Infinity Pharmaceuticals Inc. |
0
|
None specified.
|
| Inhibitex, Inc. |
0
|
None specified.
|
| Integra LifeScien |
0
|
None specified.
|
| IntelliPharmaCeutics Intl Inc |
0
|
None specified.
|
| Interleukin Genetics, Inc |
0
|
None specified.
|
| InterMune, Inc. |
1
|
None specified.
|
| Isis Pharmaceutic |
0
|
None specified.
|
| ISTA Pharmaceuticals, Inc |
0
|
None specified.
|
| IVAX Diagnostics, Inc. |
0
|
None specified.
|
| Javelin Pharmaceuticals Inc. |
1
|
FDA Decision on 10/03/2010
|
| Jazz Pharmaceuticals, Inc. |
1
|
FDA Decision on 10/11/2010
|
| JMAR Technologies, Inc. |
0
|
None specified.
|
| Johnson & Johnson |
1
|
FDA Decision on 10/01/2010
|
| Kensey Nash Corporation |
0
|
None specified.
|
| Keryx Biopharmaceuticals |
2
|
None specified.
|
| King Pharmaceuticals, Inc. |
0
|
None specified.
|
| K-V Pharmaceutical Company |
0
|
None specified.
|
| Labopharm Inc. |
1
|
None specified.
|
| Lexicon Pharmaceu |
0
|
None specified.
|
| Life Technologies |
0
|
None specified.
|
| Ligand Pharmaceuticals Inc. |
0
|
None specified.
|
| Luminex Corporati |
0
|
None specified.
|
| MannKind Corporation |
1
|
None specified.
|
| Martek Bioscience |
0
|
None specified.
|
| Matrixx Initiatives, Inc. |
0
|
None specified.
|
| Maxygen, Inc. |
0
|
None specified.
|
| MDRNA, Inc. |
0
|
None specified.
|
| MedClean Technologies Inc. |
0
|
None specified.
|
| Medical Nutrition USA, Inc. |
0
|
None specified.
|
| Medivation, Inc. |
0
|
None specified.
|
| MELA Sciences, Inc. |
1
|
None specified.
|
| Merck & Co., Inc. |
0
|
None specified.
|
| Micrus Endovascular Corporation |
0
|
None specified.
|
| Misonix, Inc. |
0
|
None specified.
|
| Molecular Insight Pharmaceuticals, Inc. |
0
|
None specified.
|
| Myriad Genetics, |
0
|
None specified.
|
| Myriad Pharmaceuticals Inc |
0
|
None specified.
|
| Nabi Biopharmaceu |
0
|
None specified.
|
| Nanogen, Inc. |
0
|
None specified.
|
| Nektar Therapeuti |
0
|
None specified.
|
| NeoStem, Inc. |
0
|
None specified.
|
| Neuralstem, Inc. |
0
|
None specified.
|
| Neurobiological Technologies, Inc. |
0
|
None specified.
|
| Neurocrine Biosci |
0
|
None specified.
|
| NeurogesX, Inc |
0
|
None specified.
|
| NexMed, Inc. |
2
|
None specified.
|
| NicOx |
1
|
None specified.
|
| NMT Medical, Inc. |
0
|
None specified.
|
| Novartis AG |
1
|
None specified.
|
| Novavax, Inc. |
0
|
None specified.
|
| Novelos Therapeutics, Inc |
1
|
None specified.
|
| NOVT Corporation |
0
|
None specified.
|
| NPS Pharmaceuticals, Inc. |
0
|
None specified.
|
| NxStage Medical, Inc. |
0
|
None specified.
|
| Nymox Pharmaceuti |
0
|
None specified.
|
| Omnicare, Inc. |
0
|
None specified.
|
| Oncothyreon |
0
|
None specified.
|
| Onyx Pharmaceuticals, Inc. |
0
|
None specified.
|
| OPKO HEALTH INC. |
0
|
None specified.
|
| Optimer Pharmaceuticals, Inc. |
0
|
None specified.
|
| OraSure Technolog |
0
|
None specified.
|
| Orchestra Therapeutics, Inc. |
0
|
None specified.
|
| Orchid Cellmark I |
0
|
None specified.
|
| Ore Pharmaceutica |
0
|
None specified.
|
| Orexigen Therapeutics, Inc. |
0
|
None specified.
|
| OSI Pharmaceutica |
0
|
None specified.
|
| Osiris Therapeutics, Inc. |
0
|
None specified.
|
| Osteotech, Inc. |
0
|
None specified.
|
| OXiGENE, Inc. |
0
|
None specified.
|
| OXIS International, Inc. |
0
|
None specified.
|
| Pain Therapeutics |
0
|
None specified.
|
| Palomar Medical Technologies, Inc. |
0
|
None specified.
|
| Panacos Pharmaceu |
0
|
None specified.
|
| Par Pharmaceutical Companies, Inc. |
1
|
None specified.
|
| PDL BioPharma, In |
0
|
None specified.
|
| Peregrine Pharmac |
0
|
None specified.
|
| Pfizer, Inc. |
0
|
None specified.
|
| Pharmacyclics, Inc.Pharmacyclics, Inc. |
0
|
None specified.
|
| PharmChem, Inc. |
0
|
None specified.
|
| Poniard Pharmaceuticals, Inc. |
1
|
None specified.
|
| Power3 Medical Products, Inc. |
0
|
None specified.
|
| POZEN Inc. |
1
|
None specified.
|
| Pressure BioSciences, Inc |
0
|
None specified.
|
| Pro-Dex, Inc |
0
|
None specified.
|
| Progenics Pharmac |
1
|
None specified.
|
| Protalix BioTherapeutics Inc |
1
|
FDA Decision on 10/27/2010
|
| Protein Polymer Technologies, Inc. |
0
|
None specified.
|
| Protox Therapeutics |
1
|
None specified.
|
| ProUroCare Medical Inc |
0
|
None specified.
|
| Provectus Pharmaceuticals, Inc. |
0
|
None specified.
|
| QLT Inc. |
0
|
None specified.
|
| Quest Diagnostics Incorporated |
0
|
None specified.
|
| Questcor Pharmaceuticals, Inc. |
1
|
None specified.
|
| Quick-Med Technologies, Inc |
0
|
None specified.
|
| Quidel Corporatio |
0
|
None specified.
|
| Regeneron Pharmac |
0
|
None specified.
|
| Repligen Corporation |
0
|
None specified.
|
| Repros Therapeuti |
0
|
None specified.
|
| Response Genetics, Inc. |
0
|
None specified.
|
| Rexahn Pharmaceuticals, Inc |
0
|
None specified.
|
| Rigel Pharmaceuticals, Inc. |
0
|
None specified.
|
| Roche Holding Ltd. |
1
|
None specified.
|
| Rosetta Genomics Ltd. |
0
|
None specified.
|
| RTI Biologics, In |
0
|
None specified.
|
| Safeguard Scientifics, Inc |
0
|
None specified.
|
| Salix Pharmaceuticals, Ltd. |
0
|
None specified.
|
| Sangamo BioScienc |
0
|
None specified.
|
| SciClone Pharmace |
0
|
None specified.
|
| Seattle Genetics, |
0
|
None specified.
|
| Senesco Technologies Inc. |
0
|
None specified.
|
| SenoRx, Inc. |
0
|
None specified.
|
| Sepracor Inc. |
0
|
None specified.
|
| Sequenom, Inc. |
0
|
None specified.
|
| Shire Plc. |
1
|
None specified.
|
| SIGA Technologies, Inc. |
0
|
None specified.
|
| Sinovac Biotech Ltd. |
0
|
None specified.
|
| Solta Medical Inc. |
0
|
None specified.
|
| Somaxon Pharmaceuticals, Inc. |
1
|
None specified.
|
| Spectrum Pharmaceuticals, Inc. |
5
|
None specified.
|
| SRI/Surgical Express, Inc. |
0
|
None specified.
|
| Stereotaxis, Inc |
0
|
None specified.
|
| Strategic Diagnos |
0
|
None specified.
|
| Sunesis Pharmaceuticals, Inc. |
0
|
None specified.
|
| SuperGen, Inc. |
0
|
None specified.
|
| SurModics, Inc. |
0
|
None specified.
|
| Symbollon Pharmaceuticals, Inc. |
0
|
None specified.
|
| Synbiotics Corporation |
0
|
None specified.
|
| Synergetics USA Inc |
0
|
None specified.
|
| Targeted Genetics Corporation |
0
|
None specified.
|
| Telik, Inc. |
0
|
None specified.
|
| Teva Pharmaceutical Industries Ltd (ADR) |
1
|
None specified.
|
| The Medicines Com |
0
|
None specified.
|
| The Spectranetics Corporation |
0
|
None specified.
|
| Theragenics Corporation |
0
|
None specified.
|
| Theratechnologies Inc. |
1
|
None specified.
|
| Theravance, Inc. |
0
|
None specified.
|
| Threshold Pharmac |
0
|
None specified.
|
| Titan Pharmaceuticals, Inc. |
0
|
None specified.
|
| TranS1 Inc. |
0
|
None specified.
|
| Transgenomic, Inc. |
0
|
None specified.
|
| Transition Therapeutics Inc. |
0
|
None specified.
|
| Trimeris, Inc. |
0
|
None specified.
|
| Trinity Biotech p |
0
|
None specified.
|
| Trubion Pharmaceuticals, Inc. |
0
|
None specified.
|
| Unigene Laboratories |
0
|
None specified.
|
| Unilife Medical Solutions |
0
|
None specified.
|
| United Therapeutics Corporation |
0
|
None specified.
|
| Urigen Pharmaceuticals, Inc. |
0
|
None specified.
|
| Vasogen Inc. |
0
|
None specified.
|
| VaxGen, Inc. |
0
|
None specified.
|
| Verenium Corporation |
0
|
None specified.
|
| Vermillion, Inc. |
0
|
None specified.
|
| Vernalis plc (ADR) |
0
|
None specified.
|
| Vertex Pharmaceuticals Incorporated |
0
|
None specified.
|
| Vical Incorporated |
0
|
None specified.
|
| Viking Systems, Inc. |
0
|
None specified.
|
| ViroPharma Incorp |
0
|
None specified.
|
| Vivus, Inc. |
1
|
FDA Decision on 10/28/2010
|
| Waters Corporation |
0
|
None specified.
|
| Watson Pharmaceuticals, Inc. |
0
|
None specified.
|
| XenoPort, Inc. |
1
|
None specified.
|
| Xoma Ltd |
0
|
None specified.
|
| YM BioSciences Inc. |
0
|
None specified.
|
| ZIOPHARM Oncology Inc. |
0
|
None specified.
|